Revenue segments as reported by the company.

U.S. Healthcare Solutions

International Healthcare Solutions

Pharmaceutical Distribution Services

Other

Intersegment eliminations

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Distribution, selling, and administrative

Depreciation and amortization

Employee severance, litigation, and other

Goodwill impairment

Impairment of assets

Acquisition, integration, and restructuring expenses

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

AmerisourceBergen

AmerisourceBergen Corp. engages in the provision of pharmaceutical products and business solutions that improve access to care. It operates through the Pharmaceutical Distribution Services and Other segments. The Pharmaceutical Distribution Services segment distributes an offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, and long-term care and alternate site pharmacies. The Other segment focuses on global commercialization services and animal health, and includes AmerisourceBergen Consulting Services ABCS, World Courier, and MWI. The company was founded by in Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Apple

AMETEK

Cintas Corp

Eaton

W.W. Grainger

Ingersoll-Rand

Lennar

Oracle

Parker-Hannifin

Still waiting for the ongoing S&P 500 rally to hit historic proportions? It just did for an elite class of stocks reaching all-time highs.

10 Stocks Soar To Highs Investors Have Never Seen Before

CONSHOHOCKEN, Pa. & SAN FRANCISCO & FORT WORTH, Texas--(BUSINESS WIRE)--TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced the completion of their previously announced acquisition of OneOncology, a network of leading oncology practices. TPG has acquired a majority interest in OneOncology, and AmerisourceBergen has acquired a minority interest in the company. OneOncology's affiliated practices, physicians, and management t.

TPG and AmerisourceBergen Announce Completion of Acquisition of OneOncology

AmerisourceBergen (ABC) reported earnings 30 days ago. What's next for the stock?

Why Is AmerisourceBergen (ABC) Up 2% Since Last Earnings Report?

In the past quarter, AmerisourceBergen (+9.37%) has experienced superior share price action to both the market (SPY: -0.16%) and the healthcare industry (IXHC: +0.93%). This is reflective of the inelastic nature - thus reduced recessionary impact - of the company's services as well as scale expansion.

AmerisourceBergen: Focused On Megatrend-Driven Margin Expansion

Walgreens

Walgreens Boots Alliance has sold shares of AmerisourceBergen for proceeds of $694 million, which will be used "primarily for debt paydown and general corporate purposes."

Walgreens Sells AmerisourceBergen Shares To Raise $694 Million To Pay Down Debt

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens Boots Alliance's entry into certain variable pre-paid forward transactions executed in reliance on Rule 144 under the Securities Act of 1933, as amended. AmerisourceBergen intends to repurchase shares from Walgreens Boots Allianc.

AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance

DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Boots Alliance sells shares of AmerisourceBergen Corporation for $694 million of initial proceeds.

Walgreens Boots Alliance Sells Shares of AmerisourceBergen Corporation for $694 Million of Initial Proceeds

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Should Value Investors Buy AmerisourceBergen (ABC) Stock?

AmerisourceBergen (ABC) is well positioned to outperform the market, as it exhibits above-average growth in financials.

3 Reasons Growth Investors Will Love AmerisourceBergen (ABC)

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen (AB), a global healthcare company, has announced a strategic partnership with SteadyMD, a B2B telehealth infrastructure provider that powers high-quality telehealth patient experiences for leaders and innovators in healthcare. The two organizations have kicked off their collaboration with the cocreation of a telehealth solution focused on Test to Treat opportunities. The solution is being offered as a pilot to independent community pharmacie.

AmerisourceBergen Announces Pharmacy Telehealth Partnership with SteadyMD

Here is how AmerisourceBergen (ABC) and Align Technology (ALGN) have performed compared to their sector so far this year.

Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?

AmerisourceBergen's (ABC) fiscal second-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.

AmerisourceBergen (ABC) Beats on Q2 Earnings, Ups '23 EPS View

AmerisourceBergen Corporation (NYSE:ABC ) Q2 2023 Results Conference Call May 2, 2023 8:30 AM ET Company Participants Bennett Murphy - Head of IR Steve Collis - Chairman, President and CEO Jim Cleary - Executive Vice President and CFO Conference Call Participants Lisa Gill - JPMorgan Elizabeth Anderson - Evercore Eric Percher - Nephron Research Erin Wright - Morgan Stanley Charles Rhyee - TD Cowen Michael Cherny - Bank of America Steven Valiquette - Barclays Daniel Grosslight - Citi George Hill - Deutsche Bank Operator Good morning, and good afternoon, everyone, and welcome to the AmerisourceBergen's Q2 Fiscal Year 2023 Earnings Call. My name is Emily, and I'll be coordinating your call today.

AmerisourceBergen Corporation (ABC) Q2 2023 Earnings Call Transcript

AmerisourceBergen (ABC) came out with quarterly earnings of $3.50 per share, beating the Zacks Consensus Estimate of $3.29 per share. This compares to earnings of $3.22 per share a year ago.

AmerisourceBergen (ABC) Beats Q2 Earnings and Revenue Estimates

AmerisourceBergen Corp.'s stock ABC rose 0.8% premarket Tuesday, after the pharmaceutical services company's fiscal second-quarter earnings blew past estimates. The company had net income of $435.4 million, or $2.13 a share, for the quarter to March 31, down from $548.0 million, or $2.59 a share, in the year-earlier period.

AmerisourceBergen stock pops premarket after earnings blow past estimates

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2023 second quarter ended March 31, 2023, revenue increased 9.9 percent year-over-year to $63.5 billion. On the basis of U.S. generally accepted accounting principles (GAAP), diluted earnings per share (EPS) was $2.13 for the second quarter of fiscal 2023 compared to $2.59 in the prior year second quarter. Adjusted diluted EPS, which is a non-GAAP financial measure that excludes.

AmerisourceBergen Reports Fiscal 2023 Second Quarter Results

AmerisourceBergen's (ABC) fiscal 2023 second-quarter results are likely to reflect solid performance in the U.S. Healthcare Solutions segment.

AmerisourceBergen (ABC) to Post Q2 Earnings: What's in Store?

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen, a global healthcare company, today announced the launch of its Cell and Gene Therapy (CGT) Integration Hub, a system that can be integrated with biopharma or provider-facing platforms to facilitate real-time data exchange and help orchestrate services across the treatment development and patient journey. The CGT Integration Hub – which is platform-agnostic and powered by AmerisourceBergen's innovative customer relationship management (CRM).

AmerisourceBergen Launches Cell and Gene Therapy Integration Hub

AmerisourceBergen Launches Cell and Gene Therapy Innovation Hub

AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes.

AmerisourceBergen's (ABC) New JV to Boost Oncology Care

Asset management firm TPG Inc. TPG, +3.12% and pharmaceutical services company AmerisourceBergen Corp. ABC, -1.75% announced Thursday an agreement to buy oncology practices network OneOncology from private equity firm General Atlantic in a deal that values OneOncology at $2.1 billion. After the deal closes, which is expected to occur by the end of September 2023, TPG will own a majority of OneOncology, and AmerisourceBergen will pay $685 million in cash for a 35% stake.

TPG, AmerisourceBergen to OneOncology in a deal that values the oncology practices network at $2.1 billion

NASHVILLE, TN., CONSHOHOCKEN, PA., SAN FRANCISCO AND FORT WORTH, TEXAS--(BUSINESS WIRE)--TPG (NASDAQ: TPG), a global alternative asset management firm, and AmerisourceBergen Corporation (NYSE: ABC) today announced that they have agreed to acquire OneOncology, a network of leading oncology practices, from General Atlantic, a leading global growth equity firm. TPG has agreed to acquire a majority interest in OneOncology, and AmerisourceBergen will acquire a minority interest in the company.

TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic

AbbVie

Best Buy

Cigna

ConocoPhillips

Cisco Systems

CVS Health

Dell Technologies

Devon Energy

eBay

Expeditors International of Washington

Twenty-First Century Fox

Gilead Sciences

KLA-Tencor

Lam Research

McKesson

Altria

Mosaic

Marathon Petroleum

Nutrien

Nucor

QUALCOMM

The following is a dividend portfolio strategy for large caps that score the highest amongst Joel Greenblatt's Magic Formula screener. The list follows large caps that have dividends.

Magic Formula Dividend Portfolio For April

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2023 on Tuesday, May 2, 2023, prior to the opening of trading on the New York Stock Exchange. The Company will host a conference call to discuss the results at 8:30 a.m. ET on May 2, 2023. Participating in the conference call will be: Steven H. Collis, Chairman, President & Chief Executive Officer James F.

AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release

Cardinal Health

Valero Energy

Andersons

BioNTech SE

Offerpad Solutions

Performance Food Group

While time in the market generally beats out timing the market, it's understandable that some investors may want to hold off on looking for stocks to buy. After all, equities continue to digest the sudden failure of a handful of financial institutions.

7 Stocks Set to Soar When the Market Recovers

News for AmerisourceBergen Stock (ABC)